SG149070A1 - Non-nucleotide reverse transcriptase inhibitors - Google Patents
Non-nucleotide reverse transcriptase inhibitorsInfo
- Publication number
- SG149070A1 SG149070A1 SG200809639-8A SG2008096398A SG149070A1 SG 149070 A1 SG149070 A1 SG 149070A1 SG 2008096398 A SG2008096398 A SG 2008096398A SG 149070 A1 SG149070 A1 SG 149070A1
- Authority
- SG
- Singapore
- Prior art keywords
- reverse transcriptase
- transcriptase inhibitors
- nucleotide reverse
- nucleotide
- inhibitors
- Prior art date
Links
- 239000002773 nucleotide Substances 0.000 title abstract 2
- 239000003419 rna directed dna polymerase inhibitor Substances 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0400021A SE0400021D0 (sv) | 2004-01-08 | 2004-01-08 | Non-nucleoside reverse transcriptase inhibitors |
| SE0400585A SE0400585D0 (sv) | 2004-03-09 | 2004-03-09 | NNRTI Antivirals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG149070A1 true SG149070A1 (en) | 2009-01-29 |
Family
ID=34752289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG200809639-8A SG149070A1 (en) | 2004-01-08 | 2004-12-30 | Non-nucleotide reverse transcriptase inhibitors |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7915295B2 (es) |
| EP (1) | EP1701942B1 (es) |
| JP (1) | JP4762917B2 (es) |
| AT (1) | ATE451357T1 (es) |
| AU (1) | AU2004312284B2 (es) |
| BR (1) | BRPI0418306B8 (es) |
| CA (1) | CA2550187C (es) |
| DE (1) | DE602004024584D1 (es) |
| DK (1) | DK1701942T3 (es) |
| EA (1) | EA009700B1 (es) |
| ES (1) | ES2337794T3 (es) |
| HK (1) | HK1101400A1 (es) |
| IL (1) | IL176740A (es) |
| NZ (1) | NZ548367A (es) |
| SG (1) | SG149070A1 (es) |
| WO (1) | WO2005066131A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1534276B1 (en) * | 2002-09-05 | 2008-11-05 | Medivir AB | Non-nucleoside reverse transcriptase inhibitors |
| US7388008B2 (en) | 2004-08-02 | 2008-06-17 | Ambrilia Biopharma Inc. | Lysine based compounds |
| CA2606025A1 (en) * | 2005-04-27 | 2006-11-02 | Ambrilia Biopharma Inc. | Method for improving pharmacokinetics of protease inhibitors and protease inhibitor precursors |
| AU2006319716B2 (en) | 2005-11-30 | 2012-02-02 | Taimed Biologics, Inc. | Lysine-based prodrugs of aspartyl protease inhibitors and processes for their preparation |
| GB0608876D0 (en) * | 2006-05-05 | 2006-06-14 | Medivir Ab | Combination therapy |
| WO2007136573A2 (en) * | 2006-05-15 | 2007-11-29 | Merck & Co., Inc. | Antidiabetic bicyclic compounds |
| JP5401652B2 (ja) | 2006-09-21 | 2014-01-29 | タイメッド バイオロジクス インコーポレイテッド | プロテアーゼ阻害剤 |
| EP3250552B1 (en) * | 2015-01-30 | 2019-03-27 | Genentech, Inc. | Therapeutic compounds and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW470645B (en) | 1998-01-16 | 2002-01-01 | Medivir Ab | Compound for inhibiting or preventing HIV infection, its preparation and pharmaceutical composition comprising same |
| WO1999051613A1 (en) * | 1998-04-03 | 1999-10-14 | Medivir Ab | Prodrugs of phosphorous-containing pharmaceuticals |
| SE0100733D0 (sv) * | 2001-03-05 | 2001-03-05 | Medivir Ab | Non-nucleoside reverse transcriptase inhibitors |
| SE0102867D0 (sv) | 2001-08-28 | 2001-08-28 | Medivir Ab | Non-nucleoside reverse transcriptase inhibitors |
| EP1534276B1 (en) | 2002-09-05 | 2008-11-05 | Medivir AB | Non-nucleoside reverse transcriptase inhibitors |
-
2004
- 2004-12-30 JP JP2006549182A patent/JP4762917B2/ja not_active Expired - Fee Related
- 2004-12-30 SG SG200809639-8A patent/SG149070A1/en unknown
- 2004-12-30 CA CA2550187A patent/CA2550187C/en not_active Expired - Fee Related
- 2004-12-30 EP EP04809207A patent/EP1701942B1/en active Active
- 2004-12-30 NZ NZ548367A patent/NZ548367A/en not_active IP Right Cessation
- 2004-12-30 BR BRPI0418306A patent/BRPI0418306B8/pt not_active IP Right Cessation
- 2004-12-30 WO PCT/SE2004/002034 patent/WO2005066131A1/en active Application Filing
- 2004-12-30 DK DK04809207.6T patent/DK1701942T3/da active
- 2004-12-30 DE DE602004024584T patent/DE602004024584D1/de active Active
- 2004-12-30 US US10/584,933 patent/US7915295B2/en not_active Expired - Fee Related
- 2004-12-30 AU AU2004312284A patent/AU2004312284B2/en not_active Ceased
- 2004-12-30 ES ES04809207T patent/ES2337794T3/es active Active
- 2004-12-30 EA EA200601289A patent/EA009700B1/ru not_active IP Right Cessation
- 2004-12-30 AT AT04809207T patent/ATE451357T1/de not_active IP Right Cessation
-
2006
- 2006-07-06 IL IL176740A patent/IL176740A/en not_active IP Right Cessation
-
2007
- 2007-08-29 HK HK07109407.1A patent/HK1101400A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2550187C (en) | 2012-08-07 |
| JP2007519640A (ja) | 2007-07-19 |
| EP1701942B1 (en) | 2009-12-09 |
| BRPI0418306B8 (pt) | 2021-05-25 |
| NZ548367A (en) | 2010-06-25 |
| US20080070951A1 (en) | 2008-03-20 |
| JP4762917B2 (ja) | 2011-08-31 |
| DE602004024584D1 (de) | 2010-01-21 |
| AU2004312284A2 (en) | 2005-07-21 |
| WO2005066131A1 (en) | 2005-07-21 |
| AU2004312284B2 (en) | 2010-08-05 |
| DK1701942T3 (da) | 2010-04-06 |
| BRPI0418306B1 (pt) | 2018-09-18 |
| EA009700B1 (ru) | 2008-02-28 |
| ES2337794T3 (es) | 2010-04-29 |
| IL176740A (en) | 2011-09-27 |
| HK1101400A1 (en) | 2007-10-18 |
| IL176740A0 (en) | 2006-10-31 |
| US7915295B2 (en) | 2011-03-29 |
| CA2550187A1 (en) | 2005-07-21 |
| EA200601289A1 (ru) | 2006-12-29 |
| AU2004312284A1 (en) | 2005-07-21 |
| BRPI0418306A (pt) | 2007-05-02 |
| ATE451357T1 (de) | 2009-12-15 |
| EP1701942A1 (en) | 2006-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG148179A1 (en) | Benzyltriazolone compounds as non-nucleoside reverse transcriptase inhibitors | |
| IN2014CN03629A (es) | ||
| SG150511A1 (en) | Viral polymerase inhibitors | |
| NO20161397A1 (no) | Ikke-nukleosidbaserte revers-transkriptase-inhibitorer | |
| EP1750696B1 (en) | RETROVIRAL PROTEASE INHIBITORS RESISTING THEIR RESISTANCE | |
| EP1732891A4 (en) | RESISTANT PREVENTIVE INHIBITORS FOR RETROVIRAL PROTEASES | |
| CY2014013I2 (el) | Αναστολεις διπεπτιδυλ πεπτιδασης | |
| IL179398A0 (en) | Dpp-ib inhibitors | |
| EP1756092A4 (en) | NEW INHIBITORS OF RHO-KINASEN | |
| GB2432609A (en) | Method of expansion | |
| IL188615A0 (en) | Hiv reverse transcriptase inhibitors | |
| MY155249A (en) | Combinations comprising methotrexate and dhodh inhibitors | |
| SG149855A1 (en) | N-channel transistor | |
| ZA200703079B (en) | DNA-PK Inhibitors | |
| SG149831A1 (en) | Benzimidazole derivatives | |
| SG145667A1 (en) | Chronograph watch | |
| IL190081A0 (en) | Nnrt inhibitors | |
| EP1816194A4 (en) | CANCER-SPECIFIC PROLIFERATION INHIBITORS | |
| SG149070A1 (en) | Non-nucleotide reverse transcriptase inhibitors | |
| GB0421355D0 (en) | Inhibitors | |
| EP1899340A4 (en) | NON-NUCLEOSIDIC REVERSE TRANSCRIPTASE INHIBITORS | |
| ZA200800185B (en) | Hiv reverse transcriptase inhibitors | |
| ZA200605395B (en) | Non-nucleotide reverse transcriptase inhibitors | |
| GB0421356D0 (en) | Inhibitors | |
| HK1079194A1 (en) | Dipyridodiazepinones as reverse transcriptase inhibitors |